Innovacare’s Penelope Kokkinides Featured on IdeaMensch

Penelope Kokkinides is the Chief Administrative officer of InnovaCare Health, whom has been involved with the company for many years before re-joining in 2015. Before, she has held other roles in clinical operations and as the Chief Operating Officer. Her passion is for developing programs and managing care to ensure that the organization is as efficient as possible.She has held a multitude of other roles throughout her career: strategy and management for managed care were a big portion of her career. She briefly left Innovacare to take on roles at UnitedHealthCare and Touchstone Health. Her goal was to develop the company’s health and implementing a health/managed care model.

Her days don’t look the same: each day keeps her on her toes and she travels constantly. She has a great team of people whom she surrounds herself with in order to develop ideas. The team she is a part of allows her to have full synergy with in order to become her best alongside with her team. Furthermore, she is constantly thinking forward about what needs to be done on the next day. She has also had a very rewarding career which has spanned a multitude of different positions. She is very organized and focused on what needs to be done for success.InnovaCare Health is a company which provides managed healthcare services to their customers in North America. They offer high quality Medicare/Medicare Advantage plans that are sustainable and cost-effective. The company aims to redefine healthcare and offer a coordinated model of healthcare in Puerto Rico.

A coordinated approach has served InnovaCare Health’s patients well to ensure that their needs are met. The company prides itself on patient-centered leadership and on ensuring that the patient care models are sustainable.The company is designed to provide the executive leadership required to provide innovative care to patients across the country. This comes through decades of experience, as well as an emphasis on priority of the needs of patients. Members are served by a huge network of primary care providers. This network is designed to ensure that the patients’ needs are met effectively within the Puerto Rican government’s health plan. Their mission is to provide broad health coverage through a coordinated care model. This is combined with the leadership of a highly experienced executive team whom have decades of experience.

Hospital Copa Star: The Brightest Healing Light Next To God

Rede D’Or Sao Luiz (Rede D’Or), was founded in 1977 and is Brazil’s largest private hospital network and the Labs D’Or units. Rede D’Or has partnered with healthcare insurers and health management operations. The Carlyle Investment Group caters to Rede D’Or’s financial needs. The Group is a multinational private equity investor. Carlyle has spread $193 billion across a combination of 286 funds, and for more than 250 real estate investments. The Carlyle Investment group has made investments in more than 200 companies.

The Rede D’Or network employs over 33,000 individuals and 85,000 affiliated doctors. The network has over 4,500 beds in its hospitals including at least 30 oncology clinics. Annually, over 2.7 million people visit Rede D’Or’s emergency rooms. There are 170,000 surgeries and 270,000 inpatient treatments. The Labs D’Or units served 150,000 people per month.

The system’s diagnostic units and hospitals are located in Rio de Janeiro, Sao Paulo, Pernambuco and Brasilia DF. Brazil’s healthcare market is growing as a result of the Brazilians longer life expectancy as the population ages. The market for hospital services contains over 53 million people. View the design at RAF Arquitetura.

In Copacabana, referred to as one of the world’s famous beaches which run in front of Rio de Janeiro, is hosting a new unit of the Rede D’Or network, Hospital Copa Star, which commenced its operations in November 2016.

Copa Stars’ architecture is modern with all the amenities of a 5-star hotel. The hospital will have 150 beds, 45 of ICU, nine operating rooms, 105 apartments and an associated diagnostic park.

Copa Star is a “smart” hospital in that its patient rooms are accommodated with technology that manages all aspects of its operations. IPads allow the hospital patient to immediately and conveniently communicate their treating physicians and hospital staff. They are permitted to see their medical reports for full transparency is related to their treatment. They also can manage the environment of the lights and curtain in the room.

The diagnostic technology is state of the art equipment, and hospital care is to international standards. Copa Star’s medical staff consists of a multidisciplinary team of experienced professionals. There are specialists trained in innovative techniques in the areas of Neurosurgery and Cardiac Surgery. The hospital has intensive care units and neurosurgery theaters and uses robots to effectuate cures and employs telemedicine.


More than 100 medical experts and 400 workers are hired by Hospital Copa Star to provide the maintenance, clothing, supplies, and billing. On the face of it, with all the amenities of Copa Star, only the wealthiest patient could afford to be treated, and the hospital would only accept private patients. However, Hospital Copa Star will accept all forms of payment, and will also work with patient’s health plans.

Mikhail Blagosklonny and the Relationship between Aging and Cancer

Is there any direct or indirect relationship between aging and the treatment of cancer? Can cancer treatments be used to reverse the physical effects of aging? These are just some of the questions over which Mikhail Blagosklonny is best known. Blagosklonny is a trained oncologist who specializes in the study of aging and cancer.

Out of his research into the relationships between aging and cancer, Mikhail Blagosklonny ended up hypothesizing about the part played by TOR signaling in cancer and aging- a hypothesis that took the scientific world by storm. In is hypothesis, Blagosklonny proposed the use of Rapamycin to reverse the physical effects of aging and in doing so extend the lifespans of human beings. Rapamycin is one of the most popular drugs used to treat cancer in practically every part of the world and Mikhail proposed that its effects on cancer cells could be harnessed to reverse aging. Although this still remains a hypothesis to date, Mikhail Blagosklonny remains one of the best known figures in the scientific world who advocate for the use of Rapamycin for research into longevity and life extension.

Learn more:

Mikhail Blagosklonny has had an illustrious and successful academic career as well as a great career as a scientist and researcher. He earned his MD in Internal Medicine from the First Pavlov State Medical University of St. Petersburg and went on to also earn his PhD later from the same institution. In 2002 Mikhail was appointed at the New York Medical College in Valhalla, NY to serve as an associate professor and this is the position that he held until he moved over to the Ordway Research Institute where he worked as a senior scientist. It is from here that he moved to his current position at Roswell Park Cancer Institute where he works as a Professor of Oncology to date. During his work and practice Mikhail Blagosklonny has authored more than 170 scientific articles, book chapters and reviews. In addition to that he is the Founder and editor in chief of Cell Cycle and an associate editor for numerous other scientific publications setting him up as one of the leading oncologists and aging experts in the country. Read more about Mikhail at